Its production following the ISO and GMP standards makes it widely used for both peripheral neuropathy and megaloblastic anaemia
Difficulty breathing, facial swelling, or a spreading rash requires immediate evaluation
Side effects at 0.25mg (5 units) Most people experience nothing at this dose
Karanikolas GN, Koukli EM, Katsalira A, et al
Recalls & Warnings February 06, 2018 FDA Links 44 Deaths to Kratom On February 6, 2018, FDA announced it is now aware of 44 deaths associated with the use of kratom, an herb often promoted for pain relief, energy and for treating opioid withdrawal symptoms
[DOI] [PubMed] [Google Scholar] 69.Parikh N.S., Kamel H., Navi B.B., Iadecola C., Merkler A.E., Jesudian A., Dawson J., Falcone G.J., Sheth K.N., Roh D.J., et al